| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6108058 | Journal of Hepatology | 2009 | 9 Pages |
Abstract
In IDV treatment the risk of severe hyperbilirubinemia is associated with genetic variants of the UGT1A3 and UGT1A7 genes in addition to Gilbert's syndrome (UGT1A1*28). This haplotype is a useful predictor of protease inhibitor-induced side effects.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Tim O. Lankisch, Georg Behrens, Ursula Ehmer, Ulrike Möbius, Juergen Rockstroh, Michael Wehmeier, Sandra Kalthoff, Nicole Freiberg, Michael P. Manns, Reinhold E. Schmidt, Christian P. Strassburg,